Cite
Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study.
MLA
Martin Arias, Luis Hermenegildo, et al. “Cardiovascular and Gastrointestinal Safety of Selective Cyclooxygenase-2 Inhibitors: A Case/Non-Case Study.” International Journal of Clinical Pharmacy, vol. 40, no. 4, Aug. 2018, pp. 928–35. EBSCOhost, https://doi.org/10.1007/s11096-018-0705-x.
APA
Martin Arias, L. H., Martin Gonzalez, A., Sanz Fadrique, R., Salgueiro, E., & Sainz, M. (2018). Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study. International Journal of Clinical Pharmacy, 40(4), 928–935. https://doi.org/10.1007/s11096-018-0705-x
Chicago
Martin Arias, Luis Hermenegildo, Antonio Martin Gonzalez, Rosario Sanz Fadrique, Esther Salgueiro, and Maria Sainz. 2018. “Cardiovascular and Gastrointestinal Safety of Selective Cyclooxygenase-2 Inhibitors: A Case/Non-Case Study.” International Journal of Clinical Pharmacy 40 (4): 928–35. doi:10.1007/s11096-018-0705-x.